白细胞介素-话题@MedSci

#白细胞介素#

90篇内容 | 3353人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1620593, encodeId=6d6b1620593b3, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=罗氏的白细胞介素6受体单抗Satralizumab治疗视神经脊髓炎谱系障碍的临床试验成功, objectType=article, longId=184086, objectId=1b3518408695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b3518408695, replyNumber=0, likeNumber=76, createdTime=2019-12-05, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b3518408695, moduleTitle=罗氏的白细胞介素6受体单抗Satralizumab治疗视神经脊髓炎谱系障碍的临床试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b3518408695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620592, encodeId=9194162059208, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=白细胞介素4/13单抗Dupixent销售额持续增长，但未能扭转赛诺菲因流感疫苗和糖尿病药物导致的整体销售额下降, objectType=article, longId=182339, objectId=d449182339d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d449182339d2, replyNumber=0, likeNumber=0, createdTime=2019-11-05, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d449182339d2, moduleTitle=白细胞介素4/13单抗Dupixent销售额持续增长，但未能扭转赛诺菲因流感疫苗和糖尿病药物导致的整体销售额下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d449182339d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620591, encodeId=937b1620591d2, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=礼来的聚乙二醇白细胞介素-10（pegilodecakin）在胰腺癌临床试验中失败, objectType=article, longId=181646, objectId=23b918164627, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23b918164627, replyNumber=0, likeNumber=100, createdTime=2019-10-22, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23b918164627, moduleTitle=礼来的聚乙二醇白细胞介素-10（pegilodecakin）在胰腺癌临床试验中失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23b918164627)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620590, encodeId=92521620590c9, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=AP&T：血清白细胞介素-6水平升高与肝硬化患者肝性脑病的发生率相关, objectType=article, longId=180583, objectId=a88c1805836f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a88c1805836f, replyNumber=0, likeNumber=80, createdTime=2019-10-07, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a88c1805836f, moduleTitle=AP&T：血清白细胞介素-6水平升高与肝硬化患者肝性脑病的发生率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a88c1805836f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620589, encodeId=79371620589a5, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=Euro Heart Failure：白细胞介素-6在心力衰竭中的临床意义, objectType=article, longId=177457, objectId=2a5a1e74571d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a5a1e74571d, replyNumber=0, likeNumber=88, createdTime=2019-08-13, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a5a1e74571d, moduleTitle=Euro Heart Failure：白细胞介素-6在心力衰竭中的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a5a1e74571d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620588, encodeId=78e31620588af, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=赛诺菲白细胞介素4/13单抗Dupixent在严重特应性皮炎儿童患者的III期试验成功, objectType=article, longId=177128, objectId=d21f1e7128a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21f1e7128a2, replyNumber=0, likeNumber=82, createdTime=2019-08-09, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21f1e7128a2, moduleTitle=赛诺菲白细胞介素4/13单抗Dupixent在严重特应性皮炎儿童患者的III期试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d21f1e7128a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620587, encodeId=a520162058e15, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=Kyowa Hakko Kirin公布其白细胞介素-17受体A单抗brodalumab治疗轴性脊柱关节炎患者的临床3期阳性结果, objectType=article, longId=168718, objectId=1557168e1835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1557168e1835, replyNumber=0, likeNumber=102, createdTime=2019-06-20, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1557168e1835, moduleTitle=Kyowa Hakko Kirin公布其白细胞介素-17受体A单抗brodalumab治疗轴性脊柱关节炎患者的临床3期阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1557168e1835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620586, encodeId=2935162058661, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=JCLA：白细胞介素‐7基因多态性rs766736182与儿童哮喘风险相关, objectType=article, longId=167814, objectId=26c516e814bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26c516e814bb, replyNumber=0, likeNumber=0, createdTime=2019-06-08, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26c516e814bb, moduleTitle=JCLA：白细胞介素‐7基因多态性rs766736182与儿童哮喘风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26c516e814bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620585, encodeId=635716205855b, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=欧洲批准AbbVie的白细胞介素23单抗Skyrizi治疗银屑病, objectType=article, longId=165295, objectId=f4ee16529528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ee16529528, replyNumber=0, likeNumber=72, createdTime=2019-05-03, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ee16529528, moduleTitle=欧洲批准AbbVie的白细胞介素23单抗Skyrizi治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4ee16529528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620584, encodeId=c912162058403, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=Clinical and Translational Gastro：胃中非幽门螺杆菌产生的脂多糖会刺激胃上皮细胞中白细胞介素-8的产生, objectType=article, longId=163738, objectId=f544163e382b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f544163e382b, replyNumber=0, likeNumber=47, createdTime=2019-04-08, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f544163e382b, moduleTitle=Clinical and Translational Gastro：胃中非幽门螺杆菌产生的脂多糖会刺激胃上皮细胞中白细胞介素-8的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f544163e382b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620583, encodeId=50c71620583bd, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=白细胞介素-5受体单抗贝那利珠可有效治疗嗜酸性粒细胞综合症, objectType=article, longId=163661, objectId=ea51163661b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea51163661b3, replyNumber=0, likeNumber=63, createdTime=2019-04-06, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea51163661b3, moduleTitle=白细胞介素-5受体单抗贝那利珠可有效治疗嗜酸性粒细胞综合症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea51163661b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620582, encodeId=3a921620582cf, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=美国皮肤病学会报告：抗白细胞介素-1α抑制剂Bermekimab可迅速解决瘙痒症，有效治疗中度至重度难治性特应性皮炎, objectType=article, longId=162015, objectId=2f1516201561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f1516201561, replyNumber=0, likeNumber=69, createdTime=2019-03-12, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f1516201561, moduleTitle=美国皮肤病学会报告：抗白细胞介素-1α抑制剂Bermekimab可迅速解决瘙痒症，有效治疗中度至重度难治性特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f1516201561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620581, encodeId=1a8d162058109, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=FDA批准了优先审查赛诺菲的白细胞介素-4单抗Dupixent治疗鼻窦炎, objectType=article, longId=161943, objectId=954e161943f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=954e161943f4, replyNumber=0, likeNumber=74, createdTime=2019-03-10, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=954e161943f4, moduleTitle=FDA批准了优先审查赛诺菲的白细胞介素-4单抗Dupixent治疗鼻窦炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=954e161943f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620580, encodeId=3138162058014, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=1期临床证实，Boehringer Ingelheim的白细胞介素-36单抗BI 655139可显著改善全身脓疱性银屑病, objectType=article, longId=161938, objectId=c4a4161938a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a4161938a0, replyNumber=0, likeNumber=0, createdTime=2019-03-10, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a4161938a0, moduleTitle=1期临床证实，Boehringer Ingelheim的白细胞介素-36单抗BI 655139可显著改善全身脓疱性银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a4161938a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620579, encodeId=7b1016205e9ca, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=BMC Infectious Diseases：白细胞介素-6比降钙素原和C反应蛋白更能预测抗生素治疗效果, objectType=article, longId=160986, objectId=b6c71609864d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6c71609864d, replyNumber=0, likeNumber=75, createdTime=2019-02-26, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6c71609864d, moduleTitle=BMC Infectious Diseases：白细胞介素-6比降钙素原和C反应蛋白更能预测抗生素治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6c71609864d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620578, encodeId=d0c816205e85b, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=J Indian Soc Periodontol：白细胞介素-21及其与慢性牙周炎的关系, objectType=article, longId=159596, objectId=260c159596e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=260c159596e2, replyNumber=0, likeNumber=72, createdTime=2019-02-08, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=260c159596e2, moduleTitle=J Indian Soc Periodontol：白细胞介素-21及其与慢性牙周炎的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=260c159596e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620577, encodeId=dca316205e776, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=JCLA：中国汉族散发性乳腺癌患者白细胞介素18基因启动子区域多态性与易感性的相关性分析, objectType=article, longId=158348, objectId=0f58158348ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f58158348ae, replyNumber=0, likeNumber=101, createdTime=2019-01-19, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f58158348ae, moduleTitle=JCLA：中国汉族散发性乳腺癌患者白细胞介素18基因启动子区域多态性与易感性的相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f58158348ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620576, encodeId=529216205e622, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=Eur Respir J：贝那利珠单抗与白细胞介素-5抑制剂治疗重症哮喘的间接比较, objectType=article, longId=154916, objectId=395f15491642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=395f15491642, replyNumber=0, likeNumber=79, createdTime=2018-12-03, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=395f15491642, moduleTitle=Eur Respir J：贝那利珠单抗与白细胞介素-5抑制剂治疗重症哮喘的间接比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=395f15491642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620575, encodeId=8c3b16205e5bf, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=J Periodontol：吸烟者慢性牙周炎应激、血清和唾液中皮质醇及白细胞介素-1β的水平, objectType=article, longId=149617, objectId=9dca14961e39, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dca14961e39, replyNumber=0, likeNumber=84, createdTime=2018-09-27, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dca14961e39, moduleTitle=J Periodontol：吸烟者慢性牙周炎应激、血清和唾液中皮质醇及白细胞介素-1β的水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dca14961e39)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1620574, encodeId=cb5816205e463, content=<a href='/topic/show?id=25a4e1714f0' target=_blank style='color:#2F92EE;'>#白细胞介素#</a>, objectTitle=Ann Intern Med：白细胞介素-1β阻断与急性痛风和血尿酸水平的关系, objectType=article, longId=149112, objectId=14ed1491129b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14ed1491129b, replyNumber=0, likeNumber=83, createdTime=2018-09-20, rootId=0, userName=yxch43, userId=e1dc20143475, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14ed1491129b, moduleTitle=Ann Intern Med：白细胞介素-1β阻断与急性痛风和血尿酸水平的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14ed1491129b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

白细胞介素

2020-05-29

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

罗氏的白细胞介素6受体单抗Satralizumab治疗视神经脊髓炎谱系障碍的临床试验成功

2019-12-05

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

白细胞介素4/13单抗Dupixent销售额持续增长，但未能扭转赛诺菲因流感疫苗和糖尿病药物导致的整体销售额下降

2019-11-05

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

礼来的聚乙二醇白细胞介素-10（pegilodecakin）在胰腺癌临床试验中失败

2019-10-22

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

AP&T：血清白细胞介素-6水平升高与肝硬化患者肝性脑病的发生率相关

2019-10-07

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

Euro Heart Failure：白细胞介素-6在心力衰竭中的临床意义

2019-08-13

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

赛诺菲白细胞介素4/13单抗Dupixent在严重特应性皮炎儿童患者的III期试验成功

2019-08-09

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

Kyowa Hakko Kirin公布其白细胞介素-17受体A单抗brodalumab治疗轴性脊柱关节炎患者的临床3期阳性结果

2019-06-20

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

JCLA：白细胞介素‐7基因多态性rs766736182与儿童哮喘风险相关

2019-06-08

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

欧洲批准AbbVie的白细胞介素23单抗Skyrizi治疗银屑病

2019-05-03

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

Clinical and Translational Gastro：胃中非幽门螺杆菌产生的脂多糖会刺激胃上皮细胞中白细胞介素-8的产生

2019-04-08

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

白细胞介素-5受体单抗贝那利珠可有效治疗嗜酸性粒细胞综合症

2019-04-06

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

美国皮肤病学会报告：抗白细胞介素-1α抑制剂Bermekimab可迅速解决瘙痒症，有效治疗中度至重度难治性特应性皮炎

2019-03-12

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

FDA批准了优先审查赛诺菲的白细胞介素-4单抗Dupixent治疗鼻窦炎

2019-03-10

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

1期临床证实，Boehringer Ingelheim的白细胞介素-36单抗BI 655139可显著改善全身脓疱性银屑病

2019-03-10

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

BMC Infectious Diseases：白细胞介素-6比降钙素原和C反应蛋白更能预测抗生素治疗效果

2019-02-26

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

J Indian Soc Periodontol：白细胞介素-21及其与慢性牙周炎的关系

2019-02-08

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

JCLA：中国汉族散发性乳腺癌患者白细胞介素18基因启动子区域多态性与易感性的相关性分析

2019-01-19

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

Eur Respir J：贝那利珠单抗与白细胞介素-5抑制剂治疗重症哮喘的间接比较

2018-12-03

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

J Periodontol：吸烟者慢性牙周炎应激、血清和唾液中皮质醇及白细胞介素-1β的水平

2018-09-27

yxch43 (审核中...)

前往app查看评论内容

#白细胞介素#

Ann Intern Med：白细胞介素-1β阻断与急性痛风和血尿酸水平的关系

2018-09-20

科室
- - 订阅+
  - 更多科室
工具
服务